Involvement of different types of potassium channels in the antidepressant-like effect of ascorbic acid in the mouse tail suspension test

European Journal of Pharmacology

Volumn 687, Issue 1-3, 2012, Pages 21-27

  Moretti, Morgana ^a   Budni, Josiane ^a   Ribeiro, Camille Mertins ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Antidepressant; Ascorbic acid; K + channel; Tail suspension test

Indexed keywords

7 NITROINDAZOLE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; APAMIN; ASCORBIC ACID; CHARYBDOTOXIN; CROMAKALIM; GLIBENCLAMIDE; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MINOXIDIL; POTASSIUM CHANNEL; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DRUG POTENTIATION; EXPERIMENTAL TEST; FEMALE; LOCOMOTION; MALE; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; TAIL SUSPENSION TEST;

ANIMALS; ANTIDEPRESSIVE AGENTS; APAMIN; ASCORBIC ACID; BEHAVIOR, ANIMAL; CHARYBDOTOXIN; FEMALE; GLYBURIDE; HINDLIMB SUSPENSION; MALE; MICE; MOTOR ACTIVITY; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; TETRAETHYLAMMONIUM;

EID: 84862014365     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.04.041     Document Type: Article

References (50)

1. Alshuaib, W.B., Mathew, M.V., 2006. Vitamins C and E modulate neuronal potassium currents. J. Membr. Biol. 210, 193-198. (Pubitemid 44306224)
2. Aronson, J.K., 1992. Potassium channels in nervous tissue. Biochem. Pharmacol. 43, 11-14.
3. Binfaré, R.W., Rosa, A.O., Lobato, K.R., Santos, A.R.S., Rodrigues, A.L.S., 2009. Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission. Prog. Neuropsychopharmacol. Biol. Psychiatry. 33, 530-540.
4. Bobker, D.H., Williams, J.T., 1990. Ion conductance affected by 5-HT receptor subtypes in mammalian neurones. Trends Neurosci. 13, 169-173. (Pubitemid 20145136)
5. Bolotina, V.M., Najibi, S., Palacino, J.J., Pagano, P.J., Cohen, R.A., 1994. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368, 850-853. (Pubitemid 24137748)
6. Bortolatto, C.F., Jesse, C.R., Wilhelm, E.A., Nogueira, C.W., 2010. Involvement of potassium channels in the antidepressant-like effect of venlafaxine in mice. Life Sci. 86, 372-376.
7. Brocardo, P.S., Budni, J., Lobato, K.R., Kaster, M.P., Rodrigues, A.L.S., 2008. Antidepressant-like effect of folic acid: involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway. Eur. J. Pharmacol. 598, 37-42.
8. Brody, S., 2002. High-dose ascorbic acid increases intercourse frequency and improves mood: a randomized controlled clinical trial. Biol. Psychiatry 52, 371-374. (Pubitemid 35245977)
9. Budni, J., Gadotti, V.M., Kaster, M.P., Santos, A.R.S., Rodrigues, A.L.S., 2007. Role of different types of potassium channels in the antidepressant-like effect of agmatine in the mouse forced swimming test. Eur. J. Pharmacol. 575, 87-93. (Pubitemid 47576077)
10. Budni, J., Freitas, A.E., Binfaré, R.W., Rodrigues, A.L.S., 2012. Role of potassium channels in the antidepressant-like effect of folic acid in the forced swimming test in mice. Pharmacol. Biochem. Behav. 101, 148-154.
11. Choi, J.S., Choi, B.H., Ahn, H.S., Kim, M.J., Han, T.H., Rhie, D.J., Yoon, S.H., Jo, Y.H., Kim, M.S., Hahn, S.J., 2004. Fluoxetine inhibits A-type potassium currents in primary cultured rat hippocampal neurons. Brain Res. 1018, 201-207. (Pubitemid 38992820)
12. + channels. Clin. Exp. Pharmacol. Physiol. 22, 944-951.
13. Cocchi, P., Silenzi, M., Calabri, G., Salvi, G., 1980. Antidepressant effect of vitamin C. Pediatrics 65, 862-863. (Pubitemid 10110491)
14. Cook, N.S., Quast, U., 1990. Potassium channel pharmacology. In: Cook, N.S. (Ed.), Potassium Channels: Structure, Classification, Function and Therapeutic Potential. Ellis Horwood Limited, Chichester, pp. 181-255.
15. Dhir, A., Kulkarni, S.K., 2001. Nitric oxide and major depression. Nitric Oxide 24, 125-131.
16. Doggrell, S.A., Bishop, B.E., 1996. Effects of potassium channel blockers on the action potentials and contractility of the rat right ventricle. Gen. Pharmacol. 27, 379-385. (Pubitemid 26129198)
17. Elhwuegi, A.S., 2004. Central monoamines and their role in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 435-451. (Pubitemid 38490755)
18. Fernandes, D., Da Silva-Santos, J.E., Assreuy, J., 2002. Nitric oxide-induced inhibition of mouse paw edema: involvement of soluble guanylate cyclase and potassium channels. Inflamm. Res. 51, 377-384.
19. + channels and contraction of cultured smooth muscle cells of porcine coronary artery. J. Pharmacol. Exp. Ther. 256, 371-377.
20. Galeotti, N., Ghelardini, C., Caldari, B., Bartolini, A., 1999. Effect of potassium channel modulators in mouse forced swimming test. Br. J. Pharmacol. 126, 1653-1659. (Pubitemid 29182351)
21. Gehlert, D.R., Gackenheimer, S.L., 1993. Comparison of the distribution of binding sites for the potassium channel ligands [125I]apamin, [125I]charybdotoxin and [125I] iodoglyburide in the rat brain. Neuroscience 52, 191-205. (Pubitemid 23026617)
22. + channels in the central nervous system. In: Cook, N.S. (Ed.), Potassium Channels: Structure, Classification, Function and Therapeutic Potential. Ellis Horwood, Chichester, UK, pp. 348-381.
23. Harkin, A.J., Bruce, K.H., Craft, B., Paul, I.A., 1999. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur. J. Pharmacol. 372, 207-213. (Pubitemid 29255959)
24. Hugues, M., Romey, G., Duval, D., Vincent, J.P., Lazdunski, M., 1982. Apamin as a selective blocker of the calcium-dependent potassium channel in neuroblastoma cells: voltage-clamp and biochemical characterization of the toxin receptor. Proc. Natl. Acad. Sci. U. S. A. 79, 1308-1312. (Pubitemid 12105598)
25. Inan, S.Y., Yalcin, I., Aksu, F., 2004. Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation. Pharmacol. Biochem. Behav. 77, 457-464. (Pubitemid 38296804)
26. + current in rat periaqueductal gray neurons. Neuropharmacology 41, 175-185.
27. + channels (rSlo). Mol. Cells 12, 97-102.
28. Jesse, C.R., Wilhelm, E.A., Barbosa, N.B., Nogueira, C.W., 2009. Involvement of different types of potassium channels in the antidepressant-like effect of tramadol in the mouse forced swimming test. Eur. J. Pharmacol. 613, 74-78.
29. Kaster, M.P., Ferreira, P.K., Santos, A.R.S., Rodrigues, A.L.S., 2005. Effects of potassiumchannel inhibitors in the forced swimming test: possible involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav. Brain Res. 165, 204-209. (Pubitemid 41565530)
30. Kaster, M.P., Gadotti, V.M., Calixto, J.B., Santos, A.R., Rodrigues, A.L.S., 2012. Depressive-like behavior induced by tumor necrosis factor-α in mice. Neuropharmacology 62, 419-426.
31. Kobayashi, T., Washiyama, K., Ikeda, K., 2004. Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs. Neuropsychopharmacology 29, 1841-1851. (Pubitemid 39336796)
32. + channels by the antidepressant paroxetine. J. Pharmacol. Sci. 102, 278-287.
33. MacKinnon, R., 2003. Potassium channels. FEBS Lett. 555, 62-65. (Pubitemid 37431098)
34. Moretti, M., Freitas, A.E., Budni, J., Fernandes, S.C., Balen, G.D., Rodrigues, A.L.S., 2011. Involvement of nitric oxide-cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test. Behav. Brain Res. 225, 328-333.
35. Moretti, M., Colla, A., de Oliveira Balen, G., Dos Santos, D.B., Budni, J., de Freitas, A.E., Farina, M., Rodrigues, A.L.S., 2012. Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress. J. Psychiatr. Res. 46, 331-340.
36. + channels by antidepressant drugs. Eur. J. Pharmacol. 452, 35-48.
37. Redrobe, J.P., Pinot, P., Bourin, M., 1996. The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in mice. Fundam. Clin. Pharmacol. 10, 524-528. (Pubitemid 26403134)
38. Rice, M.E., 2000. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 23, 209-216. (Pubitemid 30236180)
39. Rosa, A.O., Lin, J., Calixto, J.B., Santos, A.R., Rodrigues, A.L.S., 2003. Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav. Brain Res. 144, 87-93. (Pubitemid 37011169)
40. Rosati, B., Rocchetti, M., Zaza, A., Wanke, E., 1998. Sulfonylureas blockade of neural and cardiac HERG channels. FEBS Lett. 440, 125-130. (Pubitemid 28558750)
41. Schechter, L.E., 1997. The potassium channel blockers 4-aminopyridine and tetraethylammoniumincrease the spontaneous basal release of [3H]5-hydroxytryptamine in rat hippocampal slices. J. Pharmacol. Exp. Ther. 282, 262-270. (Pubitemid 27425550)
42. Shieh, C.C., Michael, C., Sullivan, J.P., Gopalakrishnan, M., 2000. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol. Rev. 52, 557-594.
43. Shin, J.H., Chung, S., Park, E.J., Uhm, D.Y., Suh, C.K., 1997. Nitric oxide directly activates calcium-activated potassium channels from rat brain reconstituted into planar lipid bilayer. FEBS Lett. 415, 299-302. (Pubitemid 27451953)
44. Steru, L., Chermat, R., Thierry, B., Simon, P., 1985. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85, 367-370. (Pubitemid 15123115)
45. + channels: molecular determinants and function of the SK family. Nat. Rev. Neurosci. 5, 758-770.
46. Szente, M.B., Baranyi, A., Woody, C.D., 1988. Intracellular injection of apamin reduces a slow potassium current mediating after hyperpolarizations and IPSPs in neocortical neurons of cats. Brain Res. 461, 64-74.
47. Tytgat, J., Maertens, C., Daenens, P., 1997. Effect of fuoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1). Br. J. Pharmacol. 122, 1417-1424. (Pubitemid 27503933)
48. +channels in vascular smooth muscle cells. Proc. Natl. Acad. Sci. U. S. A. 85, 9360-9364.
49. +channels inhibited by hydrogen peroxide mediate abscisic acid signaling in Vicia guard cells. Cell Res. 11, 195-202.
50. Zomkowski, A.D., Engel, D., Gabilan, N.H., Rodrigues, A.L.S., 2010. Involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test. Eur. Neuropsychopharmacol. 20, 793-801.